Los puntos clave no están disponibles para este artículo en este momento.
The disposition of infliximab in patients with moderately to severely active ulcerative colitis, unlike in rheumatoid arthritis, was not affected by coadministration of immunomodulators and corticosteroids but was related to formation of antibodies to infliximab and, notably, to serum albumin levels.
Fasanmade et al. (Tue,) studied this question.